Optic neuritis
Overview
•Painful monocular vision loss - subacute onset over hours to days, ranging from mild blur to near-total loss
•Pain on eye movement - traction on inflamed optic nerve sheath; highly specific feature
•Red desaturation (dyschromatopsia) - red objects appear washed out; colour vision often first deficit to appear
•Central scotoma - most common visual field defect; papillomacular bundle involvement
•Relative afferent pupillary defect (RAPD) - Marcus Gunn pupil on swinging light test; paradoxical dilation when light swung to affected eye
•Uhthoff's phenomenon - temporary worsening with raised body temperature (exercise, hot bath); does NOT represent a new relapse
•Fundoscopy: retrobulbar neuritis (most common) - normal disc acutely; papillitis (anterior) - swollen disc; chronic - disc pallor
Investigations
🥇 First-line
•MRI brain and orbits with gadolinium - investigation of choice; gadolinium enhancement confirms active inflammation; T2/FLAIR white matter lesions stratify MS risk
•Visual acuity (Snellen), colour vision (Ishihara plates), swinging light test, visual field testing (automated perimetry), fundoscopy
🥈 Second-line
•AQP4 antibodies (NMOSD), MOG-IgG (MOGAD), FBC, CRP, ESR, ANA, ANCA, ACE, syphilis serology - for atypical/bilateral/recurrent cases
•Visual evoked potentials (VEPs) - prolonged P100 latency due to demyelination
Differential diagnosis
Optic neuritis vs anterior ischaemic optic neuropathy (AION)
| Feature | Optic neuritis | AION (GCA) |
|---|---|---|
| Age | 20-40 years | >50 years (typically >70) |
| Pain | Pain on eye movement | Headache, jaw claudication, scalp tenderness |
| Vision loss | Subacute, often recovers | Sudden, often permanent |
| Fundoscopy | Normal disc (retrobulbar) or swollen | Swollen, pale optic disc |
| Association | Multiple sclerosis | Giant cell arteritis |
| Urgent treatment | IV methylprednisolone | High-dose corticosteroids immediately |
Management
•Urgent ophthalmology referral - all patients; subsequent neurology input for MS risk stratification
•First-line (acute): methylprednisolone 1 g IV once daily for 3 days - speeds visual recovery but does NOT improve final visual acuity at 6-12 months; reserved for poor vision in fellow eye, bilateral involvement, or occupational necessity
•Mild unilateral disease: supportive monitoring - most recover spontaneously within 4-12 weeks
•MS risk: neurological referral if MRI shows demyelinating lesions; early disease-modifying therapy (e.g. interferon-beta, natalizumab) reduces risk of second demyelinating event
•Uhthoff's phenomenon: advise avoidance of hot environments; reassure it is reversible and not a new relapse
Prognosis and MS risk
•Most recover visual acuity to 6/9 or better within 4-12 weeks; subtle colour and contrast deficits may persist
•~50% of patients with MS experience optic neuritis; ~50% of first-episode optic neuritis develop MS within 15 years
•Normal MRI at presentation: ~25% MS risk at 15 years; ≥2 T2 lesions: ~72% MS risk at 15 years